Meridian Management CO Biogen Inc. Transaction History

Meridian Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 05, 2019	SELL	$219.29 - $241.72 $1.95 Million - $2.15 Million	-8,886 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$216.71 - $338.96 $19,503 - $30,506	-90 Reduced 1.0%	8,886 $2.1 Million
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $27,850 - $35,275	-100 Reduced 1.1%	8,976 $2.7 Million
Q3 2018 Oct 30, 2018	SELL	$293.51 - $383.83 $22,013 - $28,787	-75 Reduced 0.82%	9,076 $3.21 Million
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $21,889 - $26,087	85 Added 0.94%	9,151 $2.66 Million
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $9,104 - $12,876	35 Added 0.39%	9,066 $2.48 Million
Q4 2017 Feb 05, 2018	SELL	$307.64 - $344.58 $67,680 - $75,807	-220 Reduced 2.38%	9,031 $2.88 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $2.6 Million - $3.05 Million	9,251	9,251 $0

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Meridian Management CO, based on Form 13F filings with the SEC.

Stay updated on Meridian Management CO with notifications on news.